Standard BioToolsの空売り状況は、投資家がStandard BioToolsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Standard BioTools (NASDAQ:LAB) 株価情報, 空売り情報

Standard BioTools

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

CYAN

バタフライ・ネットワークおよびその他2つの5ドル未満の株ダウ平均株価指数は金曜日に50ドル以上上昇して取引を終えた。内部者が株を売買した場合、それは同社の見通しに対する彼らの信頼または懸念を示唆する。ペニー株に興味を持つ投資家やトレーダーは、この要素を総合的な投資や取引の意思決定の一因と考えることができよう。

ダウ平均株価指数は50ドルの上昇を記録　上昇の要因は？

Standard BioTools Inc

Direxion Daily S&P Biotech Bear 3X Shares

LABORATORIOS FARMACEUTICO by LABORATORIOS FARMACEUTICOS ROVI SA

Laboratorios Farmaceuticos Rovi SA

Landos Biopharma Inc COM NEW

LABS Group

Direxion Daily S&P Biotech Bull 3X Shares

METASPHERE LABS INC by METASPHERE LABS INC.

Metasphere Labs Inc

IPOs

EPSM

EPSIUM ENTERPRISE Reports Pricing Of Its IPO Of 1.25M Ordinary Shares At $4.00 Per Ordinary Share

The Company will commercialize the new formulation under the tradename EGRIFTA WR.
EGRIFTA WR will be supplied as four single-patient-use vials, each containing 11.6 mg of tesamorelin, sufficient for seven doses.

THTX

Theratechnologies Says FDA Approved Supplemental Biologics License Application For F8 Formulation Of Tesamorelin For Injection

Sea (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) has outperformed the market over the past 5 years by 6.92% on an annualized basis producing an average annual return of 23.99%. Currently, Sea has a market capitalization of $74.84 billion. 
Buying $1000 In SE: If an investor had bought $1000 of SE stock 5 years ago, it would be worth $2,966.08 today based on a price of $130.30 for SE at the time of writing.
<h3>Sea's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742939108_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

STWD

Starwood Property Prices Upsized Private Offering Of $500M Of Its 6.500% Unsecured Senior Notes Due 2030

After last week&#8217;s down-to-sideways markets and no major market events scheduled for this week, you need to brace yourself for a bumpy ride.
Until the quarterly options expire on Monday, headlines will dominate this market. If there is any whiff of new tariffs, expect a market bump.
New geopolitical tension? Another bump.
That doesn&#8217;t mean there&#8217;s nothing to trade this week. As long as tariff news doesn&#8217;t arrive, the indices will (and are) slowly trend up. And individual stocks offer even more upside potential.
Especially NVDA.
The major indices have a small amount of upside available if we have no new tariff news this week. This would translate to SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) having room to $575 but struggling beyond that. For single tickers, particularly in the semi and tech space, there is room for more upside.
In the absence of major events this week, markets will be a bit more ‘free-running' with the specter of tariffs waiting in the background and the quarterly op-ex not exerting pressures till the end of the week. 
Our one concern is the key SPY $570 level. 570 is the Bull/Bear Pivot level and the beginning of the neutral zone between 570-575. Get much above this level, and bulls take control and prices soar. Get far below it, and bulls take charge and prices tank.
But it&#8217;s also a fragile level. If the SPY closes below 570, this will put us back into negative gamma. And considering volatility has come down a lot (under 19 as of this writing), a volatility spike because of, say, a new tariff could cause a lot of losses.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXdBYo6vFwH0ZN2flaoG6EoZl2VfeDzGINY6zle0ZTv6NAZlyLCv8Hh-92ro1oIKsQz7a9Ym_x4tWQngHcoqfngtPRnXxmKuemVVCAkpCmWC4aJwZnXBinBJ7gG5iEfKhUYEnIGM_w?key=yuuB6IzeJzec1RPv_5UalRft" alt="" /></figure>
Meanwhile, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has much more room to run. The stock&#8217;s&nbsp; Bull/Bear Pivot level is currently 120, which is hovering around that price point. If it breaks out above it, that&#8217;s a signal to buy it. If it stays below, you should stay away. Any tariff surprise is unlikely to hit NVDA directly, as chip tariffs have already been raised and digested by the markets.
Along with other individual tech stocks such as Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), NVDA is a good play for this week heading into the weekend.
<h2 class="wp-block-heading">How to Spot the Market Bottom &#8211; Live on Wednesday</h2>
Everyone wants to know: When will the market bottom? The truth is, waiting for the headlines means missing the real opportunity. Wall Street veteran Matt Maley has traded through crashes, bear markets, and recoveries—and he knows what signals to watch. On Wednesday, March 26, at 6 PM ET, he's revealing his exact game plan, including the key signs the bottom is forming, how to trade before the next bull run and the stocks and sectors poised to lead the recovery. Don't wait for the news—get ahead of the market now. Register <a href="https://events2.benzinga.com/matt-maley-webinar-wed-mar26-2025-registration">HERE</a> today.
Photo: Shutterstock

Opinion

Tech

ETFs

NVDA

TSLA

Nvidia Is A Good Buy In This Sideways Market

Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) has outperformed the market over the past 20 years by 3.67% on an annualized basis producing an average annual return of 11.94%. Currently, Norfolk Southern has a market capitalization of $52.99 billion. 
Buying $1000 In NSC: If an investor had bought $1000 of NSC stock 20 years ago, it would be worth $9,473.68 today based on a price of $234.00 for NSC at the time of writing.
<h3>Norfolk Southern's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742938220_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

EXEL

Exelixis To Present Preclinical Data For Four Pipeline Molecules At AACR Annual Meeting 2025

Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) has outperformed the market over the past 15 years by 10.47% on an annualized basis producing an average annual return of 21.67%. Currently, Gartner has a market capitalization of $32.40 billion. 
Buying $100 In IT: If an investor had bought $100 of IT stock 15 years ago, it would be worth $1,865.37 today based on a price of $421.76 for IT at the time of writing.
<h3>Gartner's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742937308_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Earnings

AIRJ

AirJoule Technologies 2024 EPS $4.03 Up From $(0.30) YoY

<h3>Gainers</h3>
<ul>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) shares moved upwards by 8.1% to $0.65 during Tuesday's after-market session. The market value of their outstanding shares is at $7.4 million. </li>
<li>Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) shares rose 6.46% to $2.46. The market value of their outstanding shares is at $8.0 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock rose 5.76% to $4.95. The company's market cap stands at $19.2 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) stock rose 5.42% to $0.46. The market value of their outstanding shares is at $7.3 million. </li>
<li>Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) stock rose 5.14% to $0.19. The company's market cap stands at $11.4 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares moved upwards by 4.99% to $0.43. The company's market cap stands at $124.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) stock decreased by 23.6% to $2.91 during Tuesday's after-market session. The market value of their outstanding shares is at $100.4 million. </li>
<li>SAG Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>) stock declined by 8.5% to $0.93. The market value of their outstanding shares is at $9.2 million. </li>
<li>Raytech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAY#NASDAQ">RAY</a>) shares decreased by 6.57% to $1.85. The company's market cap stands at $32.5 million. </li>
<li>U Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCAR#NASDAQ">UCAR</a>) shares decreased by 5.31% to $2.5. The market value of their outstanding shares is at $10.5 million. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) shares fell 4.82% to $1.78. The market value of their outstanding shares is at $35.0 million. </li>
<li>Newegg Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) stock declined by 4.3% to $0.26. The company's market cap stands at $97.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

GDHG

NEGG

NWTN

RENT

SPHL

UCAR

WKHS

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>AquaBounty Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQB#NASDAQ">AQB</a>) stock increased by 75.8% to $1.19 during Tuesday's after-market session. The market value of their outstanding shares is at $4.6 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) stock increased by 24.07% to $0.67. The company's market cap stands at $2.9 million. </li>
<li>DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) stock rose 9.46% to $4.51. The market value of their outstanding shares is at $92.5 million. </li>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) stock increased by 8.68% to $0.06. The market value of their outstanding shares is at $1.5 million. </li>
<li>Chemomab Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMMB#NASDAQ">CMMB</a>) shares moved upwards by 6.43% to $1.22. The company's market cap stands at $22.9 million. </li>
<li>Bicara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAX#NASDAQ">BCAX</a>) shares rose 5.9% to $13.8. The market value of their outstanding shares is at $750.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>IMAC Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BACK#NASDAQ">BACK</a>) shares fell 25.0% to $0.15 during Tuesday's after-market session. </li>
<li>Humacyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) stock fell 19.52% to $2.31. The market value of their outstanding shares is at $297.2 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares declined by 12.27% to $3.29. The market value of their outstanding shares is at $10.3 million. The company's, Q4 earnings came out 3 days ago. </li>
<li>Galecto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLTO#NASDAQ">GLTO</a>) stock declined by 10.21% to $4.4. The company's market cap stands at $5.7 million. The company's, Q4 earnings came out 4 days ago. </li>
<li>Capstone Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPS#NASDAQ">CAPS</a>) shares fell 8.57% to $2.67. The market value of their outstanding shares is at $3.7 million. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) shares fell 8.15% to $0.9. The company's market cap stands at $12.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BACK

BCAX

CAPS

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

DBVT

GLTO

HUMA

KAPA

PLRZ

PTPI

TNON

12 Health Care Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) shares moved upwards by 23.0% to $1.07 during Tuesday's after-market session. The market value of their outstanding shares is at $23.8 million. </li>
<li>Lucas GC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) shares moved upwards by 9.32% to $0.6. The company's market cap stands at $47.5 million. </li>
<li>Galaxy Payroll Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) shares moved upwards by 5.97% to $0.78. The company's market cap stands at $14.0 million. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) stock rose 5.08% to $2.52. The market value of their outstanding shares is at $2.7 million. </li>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) shares increased by 5.05% to $0.36. The market value of their outstanding shares is at $10.9 million. </li>
<li>Babcock &amp; Wilcox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) shares increased by 5.03% to $0.9. The market value of their outstanding shares is at $85.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) shares declined by 6.7% to $0.14 during Tuesday's after-market session. The company's market cap stands at $3.8 million. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) stock decreased by 5.39% to $3.05. The market value of their outstanding shares is at $103.2 million. </li>
<li>ACV Auctions Inc. Class A Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACVA#NYSE">ACVA</a>) shares declined by 4.82% to $15.57. </li>
<li>Expion360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) stock decreased by 4.64% to $1.01. The company's market cap stands at $3.1 million. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares decreased by 4.3% to $0.49. The market value of their outstanding shares is at $3.0 million. </li>
<li>TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) shares decreased by 3.64% to $0.95. The market value of their outstanding shares is at $45.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACVA

EFSH

GLXG

GPUS

LGCL

MCRP

SFHG

SGBX

TPIC

VSTE

XPON

12 Industrials Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) stock increased by 19.5% to $0.54 during Tuesday's after-market session. The company's market cap stands at $7.7 million. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares increased by 11.66% to $0.23. The market value of their outstanding shares is at $5.8 million. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock moved upwards by 5.55% to $0.04. </li>
<li>Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) stock increased by 4.98% to $41.09. The market value of their outstanding shares is at $4.2 billion. </li>
<li>Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) stock rose 4.75% to $5.95. The market value of their outstanding shares is at $91.9 million. </li>
<li>T Stamp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) stock increased by 4.3% to $2.18. The market value of their outstanding shares is at $4.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Tungray Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) stock declined by 10.2% to $1.58 during Tuesday's after-market session. The market value of their outstanding shares is at $25.8 million. </li>
<li>X3 Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) shares decreased by 7.9% to $1.05. The market value of their outstanding shares is at $14.4 million. </li>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) stock decreased by 6.87% to $0.3. The market value of their outstanding shares is at $7.6 million. </li>
<li>Sagtec Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGT#NASDAQ">SAGT</a>) stock decreased by 4.99% to $3.24. The market value of their outstanding shares is at $40.6 million. </li>
<li>Inseego (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) shares decreased by 4.93% to $9.08. The market value of their outstanding shares is at $136.2 million. </li>
<li>Focus Universal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) shares fell 4.5% to $4.46. The market value of their outstanding shares is at $33.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BRZE

CISO

CSAI

DGLY

FCUV

IDAI

INSG

SAGT

TRSG

XTKG

12 Information Technology Stocks Moving In Tuesday's After-Market Session

NOAH

Noah Holdings Q4 Adj EPADS $0.26, Net Revenues $89.3M

If you&#8217;re analyzing contrarian opportunities in 2025, this list is worth studying. It highlights names that, despite widespread skepticism, have been <a href="https://www.benzinga.com/analyst-stock-ratings">outperforming more popular picks.</a>
In a year when Wall Street&#8217;s darlings have stumbled, some of the most unloved names in the S&amp;P 500 are quietly delivering gains that put high-conviction buys to shame—and the data may challenge how investors think about analyst ratings.
In a newsletter sent Tuesday, DataTrek Research spotlighted what it called "a truly remarkable list": the 10 S&amp;P 500 companies with the highest share of &#8216;Sell&#8217; ratings from analysts. 
&#8220;History and year-to-date returns suggest it is a good place to look for longs,&#8221; analysts suggested.
<h3 class="wp-block-heading">The Contrarian Play: Most-Hated, Yet Outperforming</h3>
&#8220;Wall Street analysts don&#8217;t put &#8216;Sell&#8217; on many stocks,&#8221; Datatrek wrote.
FactSet data shows that of the 12,320 ratings issued on S&amp;P 500 stocks, 55.7% are Buys, 38.7% are Holds, and only 5.6% are Sells.
&#8220;The percentage of Buy ratings is above its 5-year (month-end) average of 55.0%. The percentage Hold ratings is below its 5-year (month-end) average of 39.1%. The percentage of Sell ratings is also below its 5-year (month-end) average of 5.9%,&#8221; FactSet said.
Here are the 10 S&amp;P 500 stocks with the highest percentage of Sell ratings:
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Company</td>
<td>Buy</td>
<td>Hold</td>
<td>Sell</td>
</tr>
<tr>
<td>Franklin Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>)</td>
<td>0%</td>
<td>60%</td>
<td>40%</td>
</tr>
<tr>
<td>VeriSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>)</td>
<td>40%</td>
<td>20%</td>
<td>40%</td>
</tr>
<tr>
<td>Expeditors Intl. of Washington, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXPD#NYSE">EXPD</a>)</td>
<td>0%</td>
<td>61%</td>
<td>39%</td>
</tr>
<tr>
<td>T. Rowe Price Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>)</td>
<td>6%</td>
<td>59%</td>
<td>35%</td>
</tr>
<tr>
<td>Paramount Global Class B (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)</td>
<td>13%</td>
<td>52%</td>
<td>35%</td>
</tr>
<tr>
<td>FactSet Research Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>)</td>
<td>17%</td>
<td>50%</td>
<td>33%</td>
</tr>
<tr>
<td>Lennox International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>)</td>
<td>24%</td>
<td>43%</td>
<td>33%</td>
</tr>
<tr>
<td>Garmin Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NYSE">GRMN</a>)</td>
<td>10%</td>
<td>60%</td>
<td>30%</td>
</tr>
<tr>
<td>Consolidated Edison, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>)</td>
<td>6%</td>
<td>65%</td>
<td>29%</td>
</tr>
<tr>
<td>Southwest Airlines Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>)</td>
<td>20%</td>
<td>52%</td>
<td>28%</td>
</tr>
</tbody>
</table>
</figure>
As counterintuitive as it may seem, an equal-weighted portfolio of these &#8220;Sell-rated&#8221; stocks would have returned 3.89% year-to-date through March 25, 2025.
Here&#8217;s how the individual &#8220;Sell&#8221; stocks performed:
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Total Return (YTD)</td>
</tr>
<tr>
<td>Consolidated Edison, Inc.</td>
<td>19.35%</td>
</tr>
<tr>
<td>VeriSign, Inc.</td>
<td>18.78%</td>
</tr>
<tr>
<td>Paramount Global</td>
<td>11.45%</td>
</tr>
<tr>
<td>Expeditors International of Washington, Inc.</td>
<td>6.88%</td>
</tr>
<tr>
<td>Garmin Ltd.</td>
<td>6.33%</td>
</tr>
<tr>
<td>Southwest Airlines Co.</td>
<td>3.72%</td>
</tr>
<tr>
<td>Franklin Resources, Inc.</td>
<td>-1.33%</td>
</tr>
<tr>
<td>Lennox International Inc.</td>
<td>-3.62%</td>
</tr>
<tr>
<td>FactSet Research Systems Inc.</td>
<td>-8.25%</td>
</tr>
<tr>
<td>T. Rowe Price Group, Inc.</td>
<td>-14.42%</td>
</tr>
</tbody>
<tfoot>
<tr>
<td>Average</td>
<td>3.89%</td>
</tr>
</tfoot>
</table>
</figure>
That performance handily beats the -2.36% decline of the S&amp;P 500, as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), and it's miles ahead of the -10% drop in the Magnificent Seven cohort, tracked by the Roundhill Magnificent Seven ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#NYSE">MAGS</a>).
<h3 class="wp-block-heading">The "Buy" Darlings Didn't Deliver</h3>
Now, contrast that with the 10 most-loved stocks in the S&amp;P 500 — the ones with the highest percentage of Buy ratings.
This basket includes mega-cap giants like Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), all ranked in the top tier for analyst sentiment.
But the returns tell a different story. An equal-weighted portfolio of these "Buy-rated" favorites would have lost 4.44% so far in 2025.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>Buy</th>
<th>Hold</th>
<th>Sell</th>
<th>YTD Return</th>
</tr>
</thead>
<tbody>
<tr>
<td>UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)</td>
<td>97%</td>
<td>0%</td>
<td>3%</td>
<td>+1.97%</td>
</tr>
<tr>
<td>Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>)</td>
<td>96%</td>
<td>0%</td>
<td>4%</td>
<td>-19.34%</td>
</tr>
<tr>
<td>VICI Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VICI#NYSE">VICI</a>)</td>
<td>96%</td>
<td>4%</td>
<td>0%</td>
<td>+9.77%</td>
</tr>
<tr>
<td>Microsoft Corp. </td>
<td>95%</td>
<td>5%</td>
<td>0%</td>
<td>-6.08%</td>
</tr>
<tr>
<td>Amazon.com Inc.</td>
<td>95%</td>
<td>5%</td>
<td>0%</td>
<td>-6.22%</td>
</tr>
<tr>
<td>Nvidia Corp.</td>
<td>93%</td>
<td>7%</td>
<td>0%</td>
<td>-10.14%</td>
</tr>
<tr>
<td>United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>)</td>
<td>92%</td>
<td>4%</td>
<td>4%</td>
<td>-18.75%</td>
</tr>
<tr>
<td>Trimble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMB#NASDAQ">TRMB</a>)</td>
<td>92%</td>
<td>8%</td>
<td>0%</td>
<td>-0.27%</td>
</tr>
<tr>
<td>Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>)</td>
<td>91%</td>
<td>9%</td>
<td>0%</td>
<td>-5.79%</td>
</tr>
<tr>
<td>Teledyne Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>)</td>
<td>91%</td>
<td>9%</td>
<td>0%</td>
<td>+10.41%</td>
</tr>
<tr>
<td>Average</td>
<td>—</td>
<td>—</td>
<td>—</td>
<td>-4.44%</td>
</tr>
</tbody>
</table>
</figure>
Bottom line, the trend offers a striking insight: being unloved by analysts doesn't necessarily doom a stock to underperformance. 
In fact, in a year marked by pullbacks in big tech and sector rotations, contrarian plays are quietly thriving.
For those willing to swim against the tide, Wall Street's least-favored stocks may hold the key to outperformance this year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44473410/trumps-tariff-rates-could-be-double-what-market-participants-expect-goldman-sachs-warns">Trump&#8217;s Tariff Rates Could Be &#8216;Double What Market Participants Expect,&#8217; Goldman Sachs Warns</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Analyst Color

Equities

Large Cap

Sector ETFs

Analyst Ratings

AMZN

EXPD

GRMN

MAGS

MSFT

PARA

SNPS

TRMB

TROW

VICI

VRSN

Want To Buy Stocks In 2025? There's One Conflicting Place To Find Winners, Analyst Says

Humacyte Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) shares are tumbling in Tuesday&#8217;s after-hours session after the company <a href="https://www.benzinga.com/pressreleases/25/03/g44481109/humacyte-inc-announces-proposed-public-offering-of-common-stock">announced a proposed public offering</a>.
What Happened: After the market close on Tuesday, Humacyte said it commenced an underwritten public offering of common stock. The biotech platform company plans to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares sold in the offering. Pricing details were not disclosed.
Humacyte intends to use the net proceeds from the offering to fund the commercialization of SYMVESS in the vascular trauma indication, as well as for the development of product candidates in the company&#8217;s pipeline.
Humacyte had $71 million in cash, cash equivalents and restricted cash&nbsp;as of&nbsp;Sept. 30, 2024.
See Also:<a href="https://www.benzinga.com/government/regulations/25/03/44480823/debt-alarm-bells-ring-in-washington-as-moodys-ray-dalio-call-for-urgent-fiscal-discipline"> Debt Alarm Bells Ring In Washington As Moody&#8217;s, Ray Dalio Call For Urgent Fiscal Discipline</a>
<h1 class="wp-block-heading">Is HUMA A Good Stock To Buy?</h1>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action, which you can find on Benzinga's quote pages — like <a href="https://www.benzinga.com/quote/HUMA">Humacyte</a>&#8216;s page, for example — there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the period the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/HUMA">Humacyte</a> will often yield whether or not the company approved a buyback program recently. Buyback programs usually act as a support for share prices, serving as a backstop for demand.
HUMA Price Action: <a href="http://benzinga.com/quote/huma">Humacyte shares</a> were down 21.39% after hours, trading at $2.26 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
This illustration was generated using artificial intelligence via Midjourney.

Biotech

Offerings

After-Hours Center

Humacyte Shares Plunge After Hours: Here's Why

RB Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBA#NYSE">RBA</a>) has outperformed the market over the past 20 years by 3.67% on an annualized basis producing an average annual return of 11.95%. Currently, RB Global has a market capitalization of $18.45 billion. 
Buying $100 In RBA: If an investor had bought $100 of RBA stock 20 years ago, it would be worth $954.30 today based on a price of $99.88 for RBA at the time of writing.
<h3>RB Global's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742936409_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In RB Global 20 Years Ago Would Be Worth This Much Today

Macro Economic Events

Macro Notification

Econ #s

Economics

General

CORRECTION: USA API Weekly Crude Oil Stock 4.600M Barrel Draw Vs 2.500M Barrel Draw Est.; 4.593M Barrel Build Prior

To further financial stability, CISO Global has also secured extensions on convertible notes totaling $7 million.

CISO Global Says It Paid Off Its Highest-interest Loans As Part Of Its Ongoing Efforts To Strengthen Its Balance Sheet

GFL Environmental Reveals Direct Share Buyback Of 17.05M Subordinate Voting Shares From BC Partners And Intention To Buyback Up To 7.056M Subordinate Voting Shares In Secondary Offering

Press Releases

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

Standard BioTools Reports Third Quarter 2024 Financial Results

Standard BioTools to Participate in Upcoming Investor Conferences

Management

Standard BioTools Appoints Alex Kim as Chief Financial Officer

Health Care

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025

Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Standard BioTools

空売り

Standard BioTools (NASDAQ:LAB) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル